Skip to content

Envoy Medical COCH Proceeds From Related Party Debt

Proceeds From Related Party Debt at other companies

Medallion Financial logo
Medallion FinancialMFIN
$245.66M-57.8%
DWS
Dawson Geophysical CompanyDWSN
$4.25M+386%
CEP
Cantor Equity Partners IV, Inc. Class A Ordinary SharesCEPF
$152.07K+7,980%
Syntec Optics Holdings, Inc. logo
Syntec Optics Holdings, Inc.OPTX
$200K-36.9%
SHA
SharonAI Holdings, Inc. Class A Common StockSHAZ
$104.9K
SVC
Stellar V Capital Corp. Class A Ordinary SharesSVCC
$25K

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromRelatedPartyDebt.

The official record: Envoy Medical’s 10-Q, filed July 31, 2025, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's proceeds from related party debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's proceeds from related party debt?
Envoy Medical (COCH) reported proceeds from related party debt of $5M in Q2 2025.
How has Envoy Medical's proceeds from related party debt changed year-over-year?
Envoy Medical's proceeds from related party debt increased by 100.0% year-over-year, from $2.5M to $5M.
What does proceeds from related party debt mean?
The total cash inflows received from borrowing arrangements with entities or individuals affiliated with the company. This metric highlights the company's reliance on internal or related-party funding sources to support operations or liquidity needs. It is essential for assessing capital structure and potential conflicts of interest.